Atria Wealth Solutions Inc. Sells 1,196 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Key Points

• Atria Wealth Solutions Inc. reduced its stake in HCA Healthcare, Inc. by 28.1%, selling 1,196 shares during Q1, leaving it with 3,060 shares valued at approximately $1,057,000.
• Several institutional investors increased their stakes in HCA, with GAMMA Investing LLC leading the way by boosting its holdings by over 40,000% during the 1st quarter.
• HCA Healthcare reported earnings of $6.84 per share, exceeding analysts' expectations, and announced a quarterly dividend of $0.72 to be paid on September 30th.

Atria Wealth Solutions Inc. trimmed its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 28.1% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,060 shares of the company's stock after selling 1,196 shares during the period. Atria Wealth Solutions Inc.'s holdings in HCA Healthcare were worth $1,057,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Horizon Family Wealth Inc. boosted its position in HCA Healthcare by 15.1% during the 1st quarter. Horizon Family Wealth Inc. now owns 931 shares of the company's stock worth $322,000 after acquiring an additional 122 shares during the period. Thoroughbred Financial Services LLC raised its position in shares of HCA Healthcare by 6.3% during the 1st quarter. Thoroughbred Financial Services LLC now owns 20,714 shares of the company's stock worth $7,157,000 after buying an additional 1,224 shares in the last quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd increased its stake in shares of HCA Healthcare by 12.3% during the first quarter. IQ EQ FUND MANAGEMENT IRELAND Ltd now owns 3,904 shares of the company's stock valued at $1,349,000 after acquiring an additional 429 shares during the period. Allianz SE lifted its holdings in shares of HCA Healthcare by 59.4% in the first quarter. Allianz SE now owns 5,389 shares of the company's stock valued at $1,862,000 after buying an additional 2,009 shares during the period. Finally, Raiffeisen Bank International AG raised its position in HCA Healthcare by 67.3% in the first quarter. Raiffeisen Bank International AG now owns 6,646 shares of the company's stock worth $2,274,000 after acquiring an additional 2,674 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently commented on HCA shares. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Wolfe Research lowered HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Royal Bank Of Canada dropped their price target on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating on the stock in a research note on Monday, July 28th. Bank of America cut HCA Healthcare from a "buy" rating to a "neutral" rating and set a $394.00 target price for the company. in a research report on Wednesday, July 16th. Finally, Robert W. Baird increased their price objective on HCA Healthcare from $380.00 to $423.00 and gave the stock a "neutral" rating in a research note on Thursday. Nine analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $398.58.

HCA Healthcare Stock Performance

HCA Healthcare stock traded up $0.31 during mid-day trading on Friday, reaching $393.96. The company had a trading volume of 723,404 shares, compared to its average volume of 1,573,847. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a 50 day moving average of $370.31 and a 200-day moving average of $351.00. The firm has a market cap of $92.18 billion, a price-to-earnings ratio of 16.56, a PEG ratio of 1.23 and a beta of 1.39.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%. The company had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. During the same quarter last year, the firm earned $5.50 EPS. HCA Healthcare's revenue for the quarter was up 6.4% compared to the same quarter last year. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is currently 12.11%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.